EBITDA: The number was foretold by the information in the 10-K and therefore shouldn't be a surprise.
Lawsuits: The language referring to these was slightly different. The 10Q said they they must be settled for an amount covered by PZN's insurance instead of referring to the possibility of buying additional cover.
Preferred Dividend: I think I saw a statement that it will not be paid again until the rights offering is completed.
Exceptional Costs: I didn't see an estimate of the advisory and other special costs being incurred due to the company's condition.
CCA revenues: Grew from 4Q in spite of all the problems.
Deal: There was more detail about the roll-over of the bank facility. HSR clearance should come very soon and then a proxy can be filed.